Gigagen, Inc.
GigaGen - Antibody Drug Discovery With Single Cell Technology
South San Francisco, United States · Founded 2015 · $90.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 1–10
- Founded
- 2015
- Website
- gigagen.com
- Total Funding
- $90.0M
- Last Round
- $50.0M SeedMar 2021
- Rounds
- 7
About
R&D company with 6 SBIR/STTR awards from Department of Health and Human Services.
Summary
Gigagen, Inc. is a Biotech company based in South San Francisco, United States, founded in 2015. It has raised $90.0M in total across 7 rounds, most recently a $50.0M Seed round in Mar 2021. Investors include Grifols, National Science Foundation and National Cancer Institute.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2021
Sign up to see all 7 rounds
Seed through Corporate Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/gigagen-inc"><img src="https://indexed.vc/api/badge/company/gigagen-inc" alt="Gigagen, Inc. on Indexed.vc" width="260" height="76" /></a>